Nature recruited telomerase to compensate for the incomplete replicati
on of chromosomal ends (telomeres). In higher organisms, telomeres are
eroded at each cell division. Cancer cells frequently show chromosoma
l instability resulting in ring chromosomes, telomeric associations, a
nd dicentric chromosomes. As a consequence of telomeric erosion, the r
ibonucleoprotein complex termed ''telomerase'' is reactivated in a sub
population of cells. Telomerase adds a hexameric repeat of the sequenc
e 5' TTAGGG 3' to the ends of the chromosomes and hence stabilizes the
telomeric length. Telomerase is active in vertebrates mostly in germ
cells and the early stage embryo but is inactivated or repressed in so
matic cells. Detection of telomerase activity in the overwhelming majo
rity of advanced and metastatic human cancers but not in most somatic
cells implies that telomerase-dependent immortalization could contribu
te to the malignancy. Future studies on the expression and regulation
of the individual components of telomerase may enable us to clarify th
e diagnostic and therapeutic potential of telomerase in cancer.